# Retatrutide UK

> UK supplier of Body Pharm Retatrutide (LY3437943) multi-dose research pens in 32mg and 64mg
> strengths. Cold-chain dispatch, batch-tested, tracked UK delivery. All products are supplied
> strictly for in-vitro laboratory research and are not approved by the MHRA for human use.

## Products

- [Body Pharm Retatrutide 32mg Pen](https://retatrutide-uk.co.uk/#buy): Multi-dose research pen, ~16-week titration capacity.
- [Body Pharm Retatrutide 64mg Pen](https://retatrutide-uk.co.uk/#buy): High-capacity multi-dose research pen, ~24+ week capacity.

## Guides

- [Retatrutide Dosing Guide](https://retatrutide-uk.co.uk/retatrutide-dosing): Weekly titration schedule from 2mg to 12mg, pen reference and tolerability notes.
- [Retatrutide vs Tirzepatide (Mounjaro)](https://retatrutide-uk.co.uk/retatrutide-vs-tirzepatide): Triple vs dual agonist mechanism, trial outcomes and dosing compared.
- [Retatrutide vs Semaglutide (Ozempic / Wegovy)](https://retatrutide-uk.co.uk/retatrutide-vs-semaglutide): Triple agonist vs single GLP-1, weight-loss data and side effects compared.
- [Retatrutide Pen vs Vial](https://retatrutide-uk.co.uk/retatrutide-pen-vs-vial): Pre-filled pen vs reconstituted vial — accuracy, sterility, dosing time and cost.

## Policies

- [Research Purposes Only](https://retatrutide-uk.co.uk/research-purposes-only): Regulatory status, permitted and prohibited use, buyer responsibilities.
- [Refund Policy](https://retatrutide-uk.co.uk/refund-policy): Returns, refunds and the 14-day return window.
- [Privacy & Cookie Policy](https://retatrutide-uk.co.uk/privacy-policy): How personal data and cookies are handled.
- [Terms & Conditions](https://retatrutide-uk.co.uk/terms-and-conditions): Terms of sale.
- [About Us](https://retatrutide-uk.co.uk/about): Business identity and contact.

## Notes

- Retatrutide is an investigational compound; no claims of safety or efficacy for human use are made.
- Clinical figures cited on this site reference published trials (e.g. Retatrutide Phase 2, NEJM 2023; SURMOUNT-1, NEJM 2022; STEP-1, NEJM 2021).